XML 30 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 31, 2024
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

NOTE 10: STOCK-BASED COMPENSATION

Stock Options

2024 Equity Incentive Awards

There were no equity incentive awards issued during the three months ended March 31, 2024.

A summary of the Company’s stock option activity for the three months ended March 31, 2024 is as follows:

    

    

    

Weighted Average

Remaining

Weighted Average 

Contractual

    

Number of Shares

    

Exercise Price

    

Total Intrinsic Value

    

Life (in years)

Outstanding as of January 1, 2024

 

737,895

$

25.42

$

1,317,000

7.6

Exercised

(19,497)

2.52

Canceled/Expired

 

(79,196)

52.95

Outstanding as of March 31, 2024

 

639,202

$

22.71

$

720,000

7.5

Options vested and exercisable

 

329,916

$

41.17

$

113,000

6.2

The following table sets forth stock-based compensation expenses recorded during the respective periods:

    

For the Three Months Ended

March 31, 

    

2024

    

2023

Stock Compensation expenses:

 

  

 

  

Research and development

$

6,000

$

151,000

General and administrative

 

73,000

 

221,000

Stock compensation in continuing operations

79,000

372,000

Stock compensation in discontinued operations

288,000

Total stock compensation expenses

$

79,000

$

660,000

As of March 31, 2024, the total stock-based compensation cost related to unvested awards not yet recognized was $0.3 million. The expected weighted average period compensation costs to be recognized was approximately 1.8 years. Future option grants will impact the compensation expense recognized.